Company intelligence / Profile preview

Conisus

Atlanta, Georgia, United States

Ownership: Private
Employees: ~175
Development stage: Other

Overview

Conisus is a specialized medical communications agency that provides strategic, scientific, and educational services to the biopharmaceutical industry, with a core focus on oncology and hematology. The company offers a comprehensive suite of services including medical affairs strategy, promotional medical education, speaker bureau management, and scientific platform development. By integrating deep clinical knowledge with creative execution, Conisus assists clients in translating complex data into actionable insights for healthcare professionals. In March 2023, Conisus was acquired by Lockwood, a leading medical communications and medical affairs firm, to enhance their combined expertise in high-science therapeutic areas.

Industry: Consulting

Beyond the preview

Go deeper on Conisus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conisus.

Explore the full profile